Literature DB >> 24077456

Radioprotection of lung tissue by soy isoflavones.

Gilda G Hillman1, Vinita Singh-Gupta, Fulvio Lonardo, David J Hoogstra, Lisa M Abernathy, Christopher K Yunker, Shoshana E Rothstein, Joseph Rakowski, Fazlul H Sarkar, Shirish Gadgeel, Andre A Konski, Michael C Joiner.   

Abstract

INTRODUCTION: Radiation-induced pneumonitis and fibrosis have restricted radiotherapy for lung cancer. In a preclinical lung tumor model, soy isoflavones showed the potential to enhance radiation damage in tumor nodules and simultaneously protect normal lung from radiation injury. We have further dissected the role of soy isoflavones in the radioprotection of lung tissue.
METHODS: Naive Balb/c mice were treated with oral soy isoflavones for 3 days before and up to 4 months after radiation. Radiation was administered to the left lung at 12 Gy. Mice were monitored for toxicity and breathing rates at 2, 3, and 4 months after radiation. Lung tissues were processed for histology for in situ evaluation of response.
RESULTS: Radiation caused damage to normal hair follicles, leading to hair loss in the irradiated left thoracic area. Supplementation with soy isoflavones protected mice against radiation-induced skin injury and hair loss. Lung irradiation also caused an increase in mouse breathing rate that was more pronounced by 4 months after radiation, probably because of the late effects of radiation-induced injury to normal lung tissue. However, this effect was mitigated by soy isoflavones. Histological examination of irradiated lungs revealed a chronic inflammatory infiltration involving alveoli and bronchioles and a progressive increase in fibrosis. These adverse effects of radiation were alleviated by soy isoflavones.
CONCLUSION: Soy isoflavones given pre- and postradiation protected the lungs against adverse effects of radiation including skin injury, hair loss, increased breathing rates, inflammation, pneumonitis and fibrosis, providing evidence for a radioprotective effect of soy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24077456      PMCID: PMC3800250          DOI: 10.1097/JTO.0b013e3182a4713e

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  32 in total

Review 1.  Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research.

Authors:  Pelagia G Tsoutsou; Michael I Koukourakis
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-01       Impact factor: 7.038

2.  Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates.

Authors:  John M Schallenkamp; Robert C Miller; Debra H Brinkmann; Tyler Foote; Yolanda I Garces
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-02-01       Impact factor: 7.038

Review 3.  Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology.

Authors:  Søren M Bentzen
Journal:  Nat Rev Cancer       Date:  2006-09       Impact factor: 60.716

Review 4.  An overview of the health effects of isoflavones with an emphasis on prostate cancer risk and prostate-specific antigen levels.

Authors:  Mark Messina; Omer Kucuk; Johanna W Lampe
Journal:  J AOAC Int       Date:  2006 Jul-Aug       Impact factor: 1.913

5.  Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis.

Authors:  Feng-Ming Kong; James A Hayman; Kent A Griffith; Gregory P Kalemkerian; Douglas Arenberg; Susan Lyons; Andrew Turrisi; Allen Lichter; Benedick Fraass; Avraham Eisbruch; Theodore S Lawrence; Randall K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-05-02       Impact factor: 7.038

6.  Repair in mouse lung after split doses of X rays.

Authors:  E L Travis; J D Down
Journal:  Radiat Res       Date:  1981-07       Impact factor: 2.841

7.  Pulmonary radiation injury: identification of risk factors associated with regional hypersensitivity.

Authors:  Alena Novakova-Jiresova; Peter van Luijk; Harry van Goor; Harm H Kampinga; Robert P Coppes
Journal:  Cancer Res       Date:  2005-05-01       Impact factor: 12.701

8.  Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.

Authors:  Julian J Raffoul; Sanjeev Banerjee; Vinita Singh-Gupta; Zvi E Knoll; Alemu Fite; Hao Zhang; Judith Abrams; Fazlul H Sarkar; Gilda G Hillman
Journal:  Cancer Res       Date:  2007-03-01       Impact factor: 12.701

9.  Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model.

Authors:  Gilda G Hillman; Yu Wang; Omer Kucuk; Mingxin Che; Daniel R Doerge; Mark Yudelev; Michael C Joiner; Brian Marples; Jeffrey D Forman; Fazlul H Sarkar
Journal:  Mol Cancer Ther       Date:  2004-10       Impact factor: 6.261

10.  Progression of renal cell carcinoma is inhibited by genistein and radiation in an orthotopic model.

Authors:  Gilda G Hillman; Yu Wang; Mingxin Che; Julian J Raffoul; Mark Yudelev; Omer Kucuk; Fazlul H Sarkar
Journal:  BMC Cancer       Date:  2007-01-09       Impact factor: 4.430

View more
  8 in total

1.  Isoflavone-mediated radioprotection involves regulation of early endothelial cell death and inflammatory signaling in Radiation-Induced lung injury.

Authors:  Matthew D Fountain; Laura A McLellan; Natalie L Smith; Brian F Loughery; Joseph T Rakowski; Harley Y Tse; Gilda G Hillman
Journal:  Int J Radiat Biol       Date:  2019-11-04       Impact factor: 2.694

2.  Soy Isoflavones Promote Radioprotection of Normal Lung Tissue by Inhibition of Radiation-Induced Activation of Macrophages and Neutrophils.

Authors:  Lisa M Abernathy; Matthew D Fountain; Shoshana E Rothstein; John M David; Christopher K Yunker; Joseph Rakowski; Fulvio Lonardo; Michael C Joiner; Gilda G Hillman
Journal:  J Thorac Oncol       Date:  2015-12       Impact factor: 15.609

3.  Axitinib Improves Radiotherapy in Murine Xenograft Lung Tumors.

Authors:  Gilda G Hillman; Fulvio Lonardo; David J Hoogstra; Joseph Rakowski; Christopher K Yunker; Michael C Joiner; Gregory Dyson; Shirish Gadgeel; Vinita Singh-Gupta
Journal:  Transl Oncol       Date:  2014-05-23       Impact factor: 4.243

4.  A Combination of Podophyllotoxin and Rutin Alleviates Radiation-Induced Pneumonitis and Fibrosis through Modulation of Lung Inflammation in Mice.

Authors:  Savita Verma; Bhargab Kalita; Sania Bajaj; Hridayesh Prakash; Ajay Kumar Singh; Manju Lata Gupta
Journal:  Front Immunol       Date:  2017-06-09       Impact factor: 7.561

5.  Innate Immune Pathways Associated with Lung Radioprotection by Soy Isoflavones.

Authors:  Lisa M Abernathy; Matthew D Fountain; Michael C Joiner; Gilda G Hillman
Journal:  Front Oncol       Date:  2017-01-23       Impact factor: 6.244

Review 6.  Reactive Oxygen Species Drive Epigenetic Changes in Radiation-Induced Fibrosis.

Authors:  Shashank Shrishrimal; Elizabeth A Kosmacek; Rebecca E Oberley-Deegan
Journal:  Oxid Med Cell Longev       Date:  2019-02-06       Impact factor: 6.543

7.  Radiation injury to cardiac arteries and myocardium is reduced by soy isoflavones.

Authors:  Michael M Dominello; Matthew D Fountain; Shoshana E Rothstein; Alexa C Cannon; Lisa M Abernathy; David Hoogstra; Wei Chen; Michael C Joiner; Gilda G Hillman
Journal:  J Radiat Oncol       Date:  2017-03-22

8.  Radiation-Induced Esophagitis is Mitigated by Soy Isoflavones.

Authors:  Matthew D Fountain; Lisa M Abernathy; Fulvio Lonardo; Shoshana E Rothstein; Michael M Dominello; Christopher K Yunker; Wei Chen; Shirish Gadgeel; Michael C Joiner; Gilda G Hillman
Journal:  Front Oncol       Date:  2015-10-21       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.